An illustration shows a molecule nestled inside a large lumpy green mass. According to researchers' predictions, the antiviral candidate, venetoclax (red and purple), could limit SARS-CoV-2's ability ...
Q. I’m immunocompromised and take medication for high blood pressure, irregular heartbeat and cholesterol. I tested positive for COVID-19 and the flu while traveling to California. Probably the plane ...
Hosted on MSN
J&J's experimental antiviral drug shows promise against COVID-19 and emerging coronaviruses
Johnson & Johnson’s pharmaceutical arm, Janssen, has shared early preclinical findings on its new antiviral drug, JNJ-9676, which shows promise in combating COVID-19 and other serious coronaviruses.
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine New antiviral drugs in development could offer the ...
A breakthrough medication may help stop COVID-19 before it starts for people exposed at home, offering hope for families with high-risk loved ones. The SCORPIO-PEP trial found the drug ensitrelvir, ...
An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on the horizon. Pfizer—the maker of Paxlovid—has begun Phase 3 clinical ...
Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...
An international clinical trial has identified a medication that can help prevent symptomatic COVID-19 in people exposed within households. The results could be particularly important for families ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results